NCT01921686View on ClinicalTrials.gov

Morphological Markers of Gastroesophageal Reflux Disease (GERD)

Active, not recruitingOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2026

Conditions
Eosinophilic EsophagitisGastroesophageal Reflux Disease
Interventions
OTHER

Sample collection and Questionnaire

This is an observational biospecimen collection and questionnaire study. The subjects will be asked to complete a symptom questionnaire at screening visit. In addition, 3 esophageal biopsy samples will be taken to conduct laboratory analyses.

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT01921686 - Morphological Markers of Gastroesophageal Reflux Disease (GERD) | Biotech Hunter | Biotech Hunter